» Articles » PMID: 34527574

Spatiotemporal Patterns of Loco-Regional Recurrence After Breast-Conserving Surgery

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 Sep 16
PMID 34527574
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Loco-regional recurrences (LRR) following breast-conserving surgery (BCS) remain a heterogeneous class of disease that has significant variation in its biological behavior and prognosis.

Methods: To delineate the spatiotemporal patterns of LRR after BCS, we analyzed the data of 4325 patients treated with BCS from 2006 to 2016. Clinico-pathological and treatment specific factors were analyzed using the Cox proportional hazards model to identify factors predictive for LRR events. Recurrence patterns were scrutinized based on recurrence type and recurrence-free interval (RFI). Annual recurrence rates (ARR) were compared according to recurrence type and molecular subtype.

Results: With a median follow-up of 66 months, 120 (2.8%) LRRs were recorded as the first site of failure. Age, pathologic stage, and molecular subtype were identified as predictors of LRR. The major recurrence type was ipsilateral breast tumor recurrence, which mainly (83.6%) occurred ≤5y post surgery. In the overall population, ARR curves showed that relapse peaked in the first 2.5 years. Patients with regional nodal recurrence, shorter RFI, and synchronous distant metastasis were associated with a poorer prognosis. HER2-positive disease had a higher rate of LRR events, more likely to have in-breast recurrence, and had an earlier relapse peak in the first 2 years after surgery.

Conclusions: LRR risk following BCS is generally low in Chinese ethnicity. Different recurrence patterns after BCS were related to distinct clinical outcomes. Management of LRR should be largely individualized and tailored to the extent of disease, the molecular profile of the recurrence, and to baseline clinical variables.

Citing Articles

Evaluation of normal tissue complications in breast cancer re-irradiation: a meta-analysis study.

Amraee A, Mokhayeri Y, Gholami M, Resane S, Evazi M, Abbasi M Clin Transl Oncol. 2024; .

PMID: 39103729 DOI: 10.1007/s12094-024-03632-z.


Magnetic resonance imaging-based prognostic model for subsequent distant metastasis in patients with ipsilateral breast tumor recurrence following breast-conserving surgery.

Li J, Qu F, Gong J, Sun S, Gu Y, You C Quant Imaging Med Surg. 2024; 14(7):4506-4519.

PMID: 39022241 PMC: 11250317. DOI: 10.21037/qims-23-1831.


Hypofractionated radiotherapy with simultaneous tumor bed boost (Hi-RISE) in breast cancer patients receiving upfront breast-conserving surgery: study protocol for a phase III randomized controlled trial.

Jin K, Luo J, Yu X, Guo X Radiat Oncol. 2024; 19(1):62.

PMID: 38802888 PMC: 11131299. DOI: 10.1186/s13014-024-02449-y.


Cost-effectiveness of intraoperative radiation therapy versus intensity-modulated radiation therapy for the treatment of early breast cancer: a disinvestment analysis.

Munoz-Montecinos C, Gonzalez-Browne C, Maza F, Carreno-Leiton D, Gonzalez P, Chahuan B BMC Health Serv Res. 2024; 24(1):417.

PMID: 38570764 PMC: 10988977. DOI: 10.1186/s12913-024-10739-0.


Ipsilateral breast tumor recurrence after breast-conserving surgery: insights into biology and treatment.

Qu F, Wu S, Li J, Shao Z Breast Cancer Res Treat. 2023; 202(2):215-220.

PMID: 37528263 DOI: 10.1007/s10549-023-07071-2.


References
1.
Davies T, Marshall J, Hazelton M . Tutorial on kernel estimation of continuous spatial and spatiotemporal relative risk. Stat Med. 2017; 37(7):1191-1221. DOI: 10.1002/sim.7577. View

2.
Moran M, Schnitt S, Giuliano A, Harris J, Khan S, Horton J . Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J Clin Oncol. 2014; 32(14):1507-15. DOI: 10.1200/JCO.2013.53.3935. View

3.
Li S, Yu K, Fan L, Hou Y, Shao Z . Predicting breast cancer recurrence following breast-conserving therapy: a single-institution analysis consisting of 764 Chinese breast cancer cases. Ann Surg Oncol. 2011; 18(9):2492-9. DOI: 10.1245/s10434-011-1626-2. View

4.
Haffty B, Yang Q, Reiss M, Kearney T, Higgins S, Weidhaas J . Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol. 2006; 24(36):5652-7. DOI: 10.1200/JCO.2006.06.5664. View

5.
Poodt I, Schipper R, de Greef B, Vugts G, Maaskant-Braat A, Jansen F . Screening for distant metastases in patients with ipsilateral breast tumor recurrence: the impact of different imaging modalities on distant recurrence-free interval. Breast Cancer Res Treat. 2019; 175(2):419-428. PMC: 6533220. DOI: 10.1007/s10549-019-05205-z. View